Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Trump’s 100% Generic Drug Duty Threatens US Low-Cost Supply
Posted
July 22, 2026
Views
2,367
Likes
28
Comments
45
Engagement
July 22, 2026
2,367
28
45
3.08%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
4:01Now PlayingGeneric drug manufacturers must move production to the US or face a 100% import duty from August 2028, President Donald Trump said, threatening the supply of low-cost medicines that millions of Americans rely on.
The move is aimed at “reshoring” generic pharmaceutical production in the US, and companies that don’t build plants onshore will face levies that would then double, to 200%, in August 2029, Trump said in a social media post. Naomi Kresge, Bloomberg Health Reporter, joins to discuss.
--------
Watch Bloomberg Radio LIVE on YouTube
Weekdays 7am-6pm ET
Saturday & Sunday 7am-10am ET
Follow us on X
Subscribe to our Podcasts:
Bloomberg Daybreak
Bloomberg Surveillance
Bloomberg Intelligence
Balance of Power
Bloomberg Businessweek
Listen on Apple CarPlay and Android Auto with the Bloomberg Business app:
Apple CarPlay
Android Auto
Visit our YouTube channels:
Bloomberg Podcasts
Bloomberg Television
Bloomberg Originals
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
